1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Microscopic Polyangiitis (MPA): new trials by email Literature Review of Microscopic Polyangiitis (MPA) trials Research Report on Microscopic Polyangiitis (MPA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. IFX-1, Placebo-IFX-1, Glucocorticoid (GC) - Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) | Phase 2 | Completed | InflaRx GmbH | 57 | 2019-04-03 | 2022-08-25 |
| Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA IFX-1 low dose, IFX-1 high dose, Placebo - Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) | Phase 2 | Terminated | InflaRx GmbH | 20 | 2018-10-15 | 2022-05-26 |
Granulomatosis with Polyangiitis (2) · Microscopic Polyangiitis (2) · Systemic Vasculitis (1)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Autoimmune Diseases (2) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebral Small Vessel Diseases (2) · Cerebrovascular Disorders (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Interstitial (2) · Nervous System Diseases (2) · Respiratory Tract Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2)
vilobelimab (2) · Glucocorticoids (1) · Prednisone (1)
InflaRx GmbH (2)
Belgium (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Russia (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Peter A. Merkel, MD, MPH (2) · Anja Pfaff, PhD (1) · Korinna Pilz, MD, MS (1)